Abbott India Ltd.

ABBOTINDIA Share PricePharmaceuticals & Drugs

28,945

95 (0.3%)

As on December 5, 2025

Exchange Scrips: BSE500488NSEABBOTINDIAISININE358A01014

Market Cap61,464 Cr

P/E Ratio 43.49

Dividend Yield 0.16 %

Performance

Market performance

Open28,850
High29,140
Volumes8,644
Prev28,945
Low28,660
As on2025-12-05

Historical performance

1 Year High37,000
3 Year High37,000
5 Year High37,000
1 Year Low25,325
3 Year Low19,900
5 Year Low13,959.8

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
61,464
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
43.49
Dividend Yield
Dividend Yield
0.16 %

Investment Returns

1 Year
-0.3%
3 Years
44.3%
5 Years
89.8%
10 Years
459.7%

Technicals

IndicatorsValueSignal
5-DMA29,147Bearish
10-DMA29,515.5Bearish
20-DMA29,530.25Bearish
50-DMA29,668Bearish
100-DMA31,127.5Bearish
200-DMA31,047.9Bearish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters33333
Foreign Investors33333
Domestic Investors---------------
Public Investors7119667581699316788969446
Government------------1

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 43.49.
  • 3Y Stock Price CAGR of the stock is 12.7.
  • The stock has a beta of 0.3.
  • In the last financial year, the company had an EBITDA of ₹19702 Million.
  • The company generated revenue of ₹64091 Million in the previous financial year.

Abbott India Ltd.

2894595   (0.3%)

Investment Amount: ₹ 1000000
Current Value: ₹ 994287.4
No. of Shares: 34 (Approx)
Performance:-0.6%
P/L: ₹-5712.6

Top Gainers

SymbolChange%
ARVEE197.48(20%)
KESORAMIND6.54(20%)
KEYFINSERV338.85(19%)
ROLLT1.37(19%)
FILATFASH0.42(14%)

Top Losers

SymbolChange%
KAYNES4353.5(-13%)
STEL547.4(-11%)
RAJSREESUG31.45(-9%)
HCC19.9(-9%)
LAGNAM67.29(-8%)
TOTAL79.43(-8%)
EASEMYTRIP7.7(-8%)
AVG163.24(-7%)

Peer Comparison

Venus Remedies Ltd.

68.1%

745.05

1 Month Performance

Nectar Lifesciences Ltd.

49.5%

20.95

1 Month Performance

Ortin Global Ltd.

36.7%

15.61

1 Month Performance

Natco Pharma Ltd.

13.9%

933.6

1 Month Performance

Haleos Labs Ltd.

13%

1335

1 Month Performance

SMS Pharmaceuticals Ltd.

12.9%

317

1 Month Performance

Ipca Laboratories Ltd.

12.7%

1459.1

1 Month Performance

Bliss GVS Pharma Ltd.

11.4%

171.23

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month